×
About 7,681 results

ALLMedicine™ Diabetic Ketoacidosis Center

Research & Reviews  2,779 results

SARS-CoV-2 Infection and Associated Rates of Diabetic Ketoacidosis in a New York City E...
https://doi.org/10.5811/westjem.2021.2.49634
The Western Journal of Emergency Medicine; Ditkowsky J, Lieber AC et. al.

Jun 14th, 2021 - In early March 2020, coronavirus 2019 (COVID-19) spread rapidly in New York City. Shortly thereafter, in response to the shelter-in-place orders and concern for infection, emergency department (ED) volumes decreased. While a connection between sev...

Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adult...
https://doi.org/10.3390/molecules26113151
Canadian Journal of Diabetes; Colacci M, Fralick J et. al.

Jun 12th, 2021 - In recent years, the use of Sideritis species as bioactive agents is increasing exponentially. The present study aimed to investigate the chemical constituents, as well as the anti-ageing potential of the cultivated Sideritis euboea Heldr. The che...

A rare case of diabetic ketoacidosis presenting with severe hypertriglyceridemia requir...
https://doi.org/10.1097/MD.0000000000026237
Medicine Roy P, Koetter P et. al.

Jun 11th, 2021 - Severe hypertriglyceridemia (HTG) is a rare complication of insulin resistance. Its presentation with diabetic ketoacidosis (DKA) has been reported in a few cases, where most patients have type-1 diabetes mellitus (DM). Our case represents a uniqu...

Sintilimab induced diabetic ketoacidosis in a patient with small cell lung cancer: A ca...
https://doi.org/10.1097/MD.0000000000025795
Medicine Huang X, Yang M et. al.

Jun 9th, 2021 - Sintilimab is a novel programmed cell death receptor-1 (PD-1) inhibitor approved in the treatment of classical Hodgkin's lymphoma and undergoing clinical trials for various malignancies. As a PD-1 inhibitor, sintilimab is known to cause autoimmune...

Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Di...
https://doi.org/10.2337/dc20-0389
Diabetes Care; Jensen ET, Stafford JM et. al.

Jun 8th, 2021 - We previously reported a high (30%) but stable prevalence of diabetic ketoacidosis (DKA) at youth-onset diagnosis of type 1 diabetes (2002 and 2010). Given the changing demographics of youth-onset type 1 diabetes, we sought to evaluate temporal tr...

see more →

Guidelines  17 results

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 16th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 10th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycem...
https://cdn.ymaws.com/www.ispad.org/resource/resmgr/consensus_guidelines_2018_/11.diabetic_ketoacidosis_and.pdf

Apr 10th, 2018 - The biochemical criteria for the diagnosis of diabetic ketoacidosis (DKA) are: Hyperglycemia (blood glucose >11 mmol/L [≈200 mg/dL]) Venous pH <7. 3 or serum bicarbonate <15 mmol/L Ketonemia (blood ß-hydroxybuyrate ≥3 mmol/L) or moderate or large k.

see more →

Drugs  697 results see all →

Clinicaltrials.gov  3,785 results

Glimepiride - glimepiride tablet-Solco Healthcare U.S., LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86acdd9e-8637-43e4-8bf7-b3a123b871b8

Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...

SARS-CoV-2 Infection and Associated Rates of Diabetic Ketoacidosis in a New York City E...
https://doi.org/10.5811/westjem.2021.2.49634
The Western Journal of Emergency Medicine; Ditkowsky J, Lieber AC et. al.

Jun 14th, 2021 - In early March 2020, coronavirus 2019 (COVID-19) spread rapidly in New York City. Shortly thereafter, in response to the shelter-in-place orders and concern for infection, emergency department (ED) volumes decreased. While a connection between sev...

Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adult...
https://doi.org/10.3390/molecules26113151
Canadian Journal of Diabetes; Colacci M, Fralick J et. al.

Jun 12th, 2021 - In recent years, the use of Sideritis species as bioactive agents is increasing exponentially. The present study aimed to investigate the chemical constituents, as well as the anti-ageing potential of the cultivated Sideritis euboea Heldr. The che...

A rare case of diabetic ketoacidosis presenting with severe hypertriglyceridemia requir...
https://doi.org/10.1097/MD.0000000000026237
Medicine Roy P, Koetter P et. al.

Jun 11th, 2021 - Severe hypertriglyceridemia (HTG) is a rare complication of insulin resistance. Its presentation with diabetic ketoacidosis (DKA) has been reported in a few cases, where most patients have type-1 diabetes mellitus (DM). Our case represents a uniqu...

Sintilimab induced diabetic ketoacidosis in a patient with small cell lung cancer: A ca...
https://doi.org/10.1097/MD.0000000000025795
Medicine Huang X, Yang M et. al.

Jun 9th, 2021 - Sintilimab is a novel programmed cell death receptor-1 (PD-1) inhibitor approved in the treatment of classical Hodgkin's lymphoma and undergoing clinical trials for various malignancies. As a PD-1 inhibitor, sintilimab is known to cause autoimmune...

see more →

News  399 results

Patients With Cancer Who Develop Ketoacidosis Fare Badly
https://www.medscape.com/viewarticle/952159

May 31st, 2021 - The clinical picture of diabetic ketoacidosis (DKA) differs in several ways among patients with cancer compared to those without cancer, new research indicates.   Traditionally, DKA has been associated with type 1 diabetes, often in younger people...

1 in 5 Hospitalized With Diabetic Ketoacidosis Is Readmitted
https://www.medscape.com/viewarticle/947922

Mar 22nd, 2021 - About one in five people with type 1 diabetes in the United States hospitalized with diabetic ketoacidosis (DKA) is readmitted within 30 days, new research shows. The results from the National Readmission Database also show that deaths are higher ...

Pumps and Patches: Technology Benefits Youth With Type 1 Diabetes
https://www.medscape.com/viewarticle/947742

Mar 18th, 2021 - An increase in the use of insulin pumps and continuous glucose monitoring (CGM) around the world is benefiting children with type 1 diabetes, new research finds. An analysis of data for more than 25,000 participants aged 18 years or younger with t...

COVID-19 Complicates Diabetic Ketoacidosis in Hospital
https://www.medscape.com/viewarticle/947200

Mar 9th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The clinical course and prognosis of individuals hospitalized with diabetic ketoacidosis (DKA) are considerably worse among those who have COVID-1...

Further Warning on SGLT2 Inhibitor Use and DKA Risk in COVID-19
https://www.medscape.com/viewarticle/944267

Jan 17th, 2021 - Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors during acute COVID-19 illness raises the risk for euglycemic diabetic ketoacidosis (euDKA), a new case series suggests. Five patients with type 2 diabetes who were taking SGLT2 inhibitors pr...

see more →

Patient Education  4 results see all →